Pharma, Biotech and Generics Industry News | The Pharmaletter
2024年11月19日 · The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research …
Pharmaceutical Industry News | The Pharmaletter
2024年11月12日 · The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research …
Pharma and Biotech News | The Pharmaletter
6 天之前 · 20 November 2024 Sweden-based Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement for the former …
Pharma and Biotech News in Brief | The Pharmaletter
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi …
FDA drug regulation and approval news | The Pharmaletter
2024年11月13日 · Intercept Pharmaceuticals, now wholly owned subsidiary of Italy’s Alfasigma, today revealed that the US Food and Drug Administration (FDA) has issued a Complete …
Pharmaceutical Generics Industry News | The Pharmaletter
2024年9月9日 · Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets.
Pharma and Biotech Insights | The Pharmaletter
Pharma and Biotech News Insights. As stakeholders in the pharmaceutical industry, we all have a responsibility to ensure life-saving treatments promptly and safely reach patients regardless of …
About The Pharma Letter | The Pharmaletter
5 天之前 · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered …
Biotech Industry News | The Pharmaletter
2024年11月11日 · Merck & Co has entered into an exclusive global license to develop, manufacture and commercialize LM-299 from China-based clinical-stage biotech LaNova …
Pharma M&A news | The Pharmaletter
2024年11月5日 · US pharma major AbbVie last week proposed $1.4 billion acquisition of US CNS drug developer Aliada Therapeutics. Last week saw a bunch of third quarter 2024 financials …